Cramer Pamela J.
SEC CIK 1873517 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS, INC. | CHRO | 34.1K | — | $10.98M | 49 | 2022-07-26 | 2026-02-01 |
Most active insiders at RYTM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lee Jennifer Kayden | EVP, Head of North America | — | $8.90M |
| 2 | Smith Hunter C | CFO | — | $8.84M |
| 3 | Mazabraud Yann | EVP, Head of International | — | $6.62M |
| 4 | Meeker David P | Pres, CEO, Dir | — | $5.13M |
| 5 | TETRAULT LYNN A. | Dir | — | $3.71M |
| 6 | Shulman Joseph | Chief Technical Off | — | $3.67M |
| 7 | Cramer Pamela J. | CHRO | — | $2.99M |
| 8 | German Christopher Paul | CAO, Corp. Ctrl | — | $930.9K |
| 9 | Garfield Alastair | CSO | — | $912.7K |
| 10 | Arbuckle Stuart A | Dir | — | — |
Transactions 49
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +13.3K | 34.1K | +64% | — |
| D | 2026-02-03 | 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | F - Tax | $108.99 | -4,731 | 29.4K | -14% | -$515.6K |
| D | 2025-12-15 | 2025-12-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $27.35 | +3,350 | 24.2K | +16% | +$91.6K |
| D | 2025-12-15 | 2025-12-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $111.00 | -3,350 | 20.8K | -14% | -$371.9K |
| D | 2025-11-24 | 2025-11-20 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $105.00 | -3,350 | 20.8K | -14% | -$351.8K |
| D | 2025-11-24 | 2025-11-20 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $27.35 | +3,350 | 24.2K | +16% | +$91.6K |
| DM | 2025-11-12 | 2025-11-07+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $99.00 | -22.9K | 20.8K | -52% | -$2.26M |
| DM | 2025-11-12 | 2025-11-07+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $11.51 | +22.9K | 29.6K | +339% | +$263.1K |
| D | 2025-07-29 | 2025-07-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $85.93 | -1,520 | 20.8K | -7% | -$130.6K |
| D | 2025-07-29 | 2025-07-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 22.3K | +16% | — |
| DM | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $77.13 | -15.6K | 22.7K | -41% | -$1.20M |
| DM | 2025-07-11 | 2025-07-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $13.43 | +15.6K | 34.8K | +81% | +$209.2K |
| D | 2025-06-10 | 2025-06-06 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $6.80 | +7,031 | 26.2K | +37% | +$47.8K |
| D | 2025-06-10 | 2025-06-06 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $68.05 | -7,031 | 19.2K | -27% | -$478.5K |
| D | 2025-05-01 | 2025-04-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $65.09 | -7,031 | 19.2K | -27% | -$457.6K |
| D | 2025-05-01 | 2025-04-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $6.80 | +7,031 | 26.2K | +37% | +$47.8K |
| DM | 2025-04-10 | 2025-04-08 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $13.43 | +20.8K | 33.3K | +166% | +$278.9K |
| DM | 2025-04-10 | 2025-04-08 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $60.14 | -20.8K | 32.9K | -39% | -$1.25M |
| D | 2025-02-19 | 2025-02-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $57.22 | -982 | 19.2K | -5% | -$56.2K |
| D | 2025-02-19 | 2025-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +3,300 | 20.2K | +20% | — |
| D | 2025-02-11 | 2025-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +2,344 | 17.6K | +15% | — |
| DM | 2025-02-11 | 2025-02-11 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $57.51 | -701 | 16.9K | -4% | -$40.3K |
| D | 2025-02-04 | 2025-02-04 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $59.43 | -902 | 15.2K | -6% | -$53.6K |
| D | 2025-02-04 | 2025-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +2,650 | 16.1K | +20% | — |
| DM | 2024-11-08 | 2024-11-06+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $62.50 | -9,375 | 13.5K | -41% | -$585.9K |
| DM | 2024-11-08 | 2024-11-06+ | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +9,375 | 18.2K | +106% | +$178.3K |
| D | 2024-09-11 | 2024-09-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +4,099 | 17.6K | +30% | +$78.0K |
| D | 2024-09-11 | 2024-09-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $50.03 | -4,099 | 13.5K | -23% | -$205.1K |
| D | 2024-08-28 | 2024-08-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $50.01 | -3,200 | 13.5K | -19% | -$160.0K |
| D | 2024-08-28 | 2024-08-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +3,200 | 16.7K | +24% | +$60.9K |
| DM | 2024-08-13 | 2024-08-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $45.15 | -49.0K | 13.5K | -78% | -$2.21M |
| D | 2024-08-13 | 2024-08-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +30.8K | 62.5K | +97% | +$585.3K |
| D | 2024-07-30 | 2024-07-29 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $49.06 | -1,395 | 31.7K | -4% | -$68.4K |
| D | 2024-07-30 | 2024-07-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 33.1K | +10% | — |
| 2024-03-19 | 2024-03-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale | $39.22 | -15.5K | 30.0K | -34% | -$608.5K | |
| D | 2024-02-21 | 2024-02-16 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | A - Grant | $0.00 | +33.8K | 45.5K | +287% | $0 |
| D | 2024-02-13 | 2024-02-12 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $51.38 | -696 | 11.8K | -6% | -$35.8K |
| D | 2024-02-13 | 2024-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +2,344 | 12.5K | +23% | — |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $45.06 | -946 | 10.1K | -9% | -$42.6K |
| D | 2024-02-05 | 2024-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +2,650 | 11.1K | +31% | — |
| D | 2023-07-28 | 2023-07-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $17.64 | -930 | 8,418 | -10% | -$16.4K |
| D | 2023-07-28 | 2023-07-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 9,348 | +50% | — |
| A | 2023-02-14 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale | $27.51 | -843 | 6,142 | -12% | -$23.2K |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +2,344 | 6,985 | +51% | — |
| D | 2023-02-13 | 2023-02-09 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $27.66 | -834 | 6,151 | -12% | -$23.1K |
| D | 2022-08-23 | 2022-08-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | $19.02 | +13.5K | 15.7K | +607% | +$256.6K |
| D | 2022-08-23 | 2022-08-19 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $24.83 | -13.5K | 2,224 | -86% | -$335.0K |
| D | 2022-07-28 | 2022-07-27 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | S - Sale+OE | $11.68 | -901 | 2,224 | -29% | -$10.5K |
| D | 2022-07-28 | 2022-07-26 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Cramer Pamela J. | CHRO | M - OptEx | — | +3,125 | 3,125 | New | — |
Purchase Sale Sale after option exercise All abbreviations